- Research article
- Open Access
miRNA regulated pathways in late stage murine lung development
BMC Developmental Biologyvolume 13, Article number: 13 (2013)
MicroRNAs play important roles in regulating biological processes, including organ morphogenesis and maturation. However, little is known about specific pathways regulated by miRNA during lung development. Between the canalicular and saccular stages of the developing lung several important cellular events occur, including the onset of surfactant synthesis, microvascular remodeling and structural preparation for subsequent alveolarization. The miRNAs that are actively regulated, and the identity of their targets during this important developmental interval in the lung remain elusive.
Using TLDA low density real-time PCR arrays, the expression of 376 miRNAs in male and female fetal mouse lungs of gestational days E15 – E18 were profiled. Statistical analyses identified 25 and 37 miRNAs that changed significantly between sexes and with gestation, respectively. In silico analysis using Ingenuity Pathway Analysis (IPA) identified specific pathways and networks known to be targets of these miRNAs which are important to lung development. Pathways that are targeted by sex regulated miRNAs include retinoin, IGFR1, Tp53 and Akt. Pathways targeted by gestation-regulated miRNAs include VEGFA and mediators of glucose metabolism.
MiRNAs are differentially regulated across time and between sexes during the canalicular and saccular stages of lung development. Sex-associated differential miRNA expression may regulate the differences in structural and functional male and female lung development, as shown by networks generated using in silico analysis. These data provide a valuable resource to further enhance the understanding of miRNA control of lung development and maturation.
It is clear that miRNAs regulate numerous important developmental processes in various organs. miRNAs are a class of small RNAs that post-transcriptionally regulate gene expression. The primary RNA (pri-miRNA) is transcribed from the genome and is processed by Drosha, an RNase III enzyme, into hairpin structured premature miRNAs (pre-miRNAs). These pre-miRNAs are exported out of the nucleus with the help of Exportin 5, and cleaved into double stranded duplexes by Dicer, another RNase III enzyme. The mature miRNAs are loaded onto nucleoprotein complexes called the RNA-induced silencing complex (RISC). The mature miRNAs in these complexes inhibit translation of target mRNAs by blocking translation or aiding in degradation of their targets .
An important role of miRNAs during lung morphogenesis has been recently established. Conditional deletion of Dicer from the lung epithelium led to arrested airway branching, dramatically altering lung organogenesis . Subsequent studies of miRNA profile expression in the lung demonstrated that miRNAs are temporally expressed between the embryonic and adult lung development [3–7].
Mouse lung development is divided into five stages: embryonic (E9.5-E11.5), pseudoglandular (E11.5-16.5), canalicular (E16.5-E17.5), saccular (E17.5-P5) and alveolar (post-natal (P)5-P30). The coordination of multiple pathways across various cellular compartments is required to give rise to a fully developed lung. The transition from the late canalicular to early saccular stage is a crucial period in preparation for survival after birth. During the canalicular stage establishment of the air-blood barrier begins and epithelial differentiation of alveolar Type I and Type II cells commences. The onset of surfactant synthesis plus microvascular development in the early saccular stage are necessary for proper lung function at birth. The timing and coordination of genetic- and sex - specific programming that occurs during these lung developmental stages are crucial regulatory elements for lung maturation . Very little is known about how miRNA expression and genetic control contributes to these critical events. The recent evidence showing the importance of miRNAs in development and disease of other organs indicates the need for more detailed studies of how miRNAs regulate pathways important in the developing lung .
The aim of this study was to analyze the dynamic regulation of miRNAs during the canalicular to early saccular stage of mouse lung development. We profiled miRNAs of lungs isolated from male and female E15-E18 fetal mouse lungs. It is well established that male infants have increased perinatal respiratory morbidity and mortality and that androgens inhibit lung maturation in males [10, 11]. In mouse lung development, the development of surfactant production during this canalicular to early saccular interval is delayed by one day in males compared to females . Several important transcription factors and signaling pathways are differentially expressed and activated in males and females during this time, suggesting that it is very likely that miRNAs may also be regulating these sex differences as well [13, 14].
In this study, we show that a group of miRNAs are differentially expressed across these gestational ages, and another group of miRNAs differentially expressed between males and females. These groups were further analyzed for pathway interactions using Ingenuity Pathway Analysis, which maps interactive pathway networks based on established miRNA targets previously reported in the literature. With the IPA analysis we are able to highlight pathways regulated by these developmentally regulated miRNA groups that are differentially expressed across gestation, and between males and females, during an important window in lung development.
The animal study protocol was approved by the Tufts Medical Center Institutional Animal Care and Use Committee. Principals of laboratory animal care were followed according to the National Institute of Health Guidelines for Care and Use of Laboratory Animals. Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories (Wilmington, MA, USA), with the morning of the vaginal plug defined as gestational day 0 (E0).
Isolation of total RNA
Timed pregnant mice at each gestational age were sacrificed using CO2 inhalation according to the approved protocol and in line with current regulations. The uterus was removed under sterile conditions by laparotomy and placed on ice. Fetuses were maintained in DMEM on ice while fetal sex was identified . The lungs were removed en block under a sterile laminar airflow hood. Lungs were frozen for RNA extraction. RNA was extracted using miRVana miRNA Isolation Kit (Ambion, Grand Island, NY) according to the manufacturer’s instructions.
A Taqman Array Rodent MicroRNA A card v2.0 (Applied Biosystems, Carlsbad, CA) was used to profile 376 mature miRNAs. cDNA was transcribed from total RNA using the Megaplex TM RT Rodent Primers Pool and the TaqMan MicroRNA Reverse Transcription Kit. The TaqMan miRNA Arrays were run on the ABI PRISM 7900 System using the TaqMan Universal PCR Master Mix according to the manufacturer’s instructions. Two array runs using separate lungs with two technical replicates per lung were performed. The data from these runs were used in the data analysis model. The delta CT was calculated by subtracting the miRNA Ct value from the Ct value of small nuclear U6 RNA, which served as a control. The data were normalized to E15 for data analysis. The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE46037 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46037).
For each miRNA, we separately evaluated the effect of gestation (time) and gender (sex), and then tested if the temporal patterns differed between males and females. We used mixed linear models with fixed main time and sex effects, their interaction effect, and random sample effect to account for any correlated nature of the data. The analyses were performed using base, nlme, and qvalue packages of statistical software R [16–18].
Cluster analysis for the miRNAs that changed significantly across gestation and with fetal sex was done using gplots package of statistical R software . Ingenuity Pathway Analysis (IPA) was used to generate pathways regulated by these miRNAs based on validated miRNA targets (Ingenuity Systems, http://www.ingenuity.com, August 2011 version).
Specific miRNAs are differentially expressed between sexes and with advancing gestation
MiRNA profiles from E15-E18 male and female mouse lungs were generated using a miRNA qPCR array (Additional file 1). Using linear mixed models we identified those miRNAs that changed significantly with gestation or with sex (p<0.05, FDR<33%). This analysis identified 37 miRNAs that significantly changed with advancing gestation and 25 miRNAs that were significantly different between males and female fetuses. A group of 13 miRNAs changed significantly with sex and gestation (interactive effect, Additional file 2). The majority of the 13 miRNAs with an interactive effect were also significant by either gestation or sex. The miRNAs that changed significantly with gestation and sex are listed in Table 1, along with their p-values, chromosomal locations, the miRNA family, and miRNA cluster that shows the number of other miRNAs located within the neighboring 10 kb chromosomal region. Fold change values are listed in Additional file 3.
Networks for miRNAs changing significantly with sex
The cluster dendrogram for miRNAs that changed significantly between the development of male and female lungs is shown in Figure 1. Sex hormones have been shown to regulate lung development. Androgens, in particular, have inhibitory effects on lung maturational events during the gestational interval studied [20–23]. Some of the identified miRNAs have similar gestational trends between males and females, but the absolute levels of miRNAs differed greatly between the sexes (Additional file 1, Additional file 3). In order to decifer the known functions of the sex-regulated miRNAs, Ingenuity Pathway Analysis software was used to generate molecular pathways based on known targets of the respective miRNAs. IPA identified two different yet related networks for those miRNAs significantly different in developing lung by sex, based on previously validated targets in the literature (Figure 2). The first network converged upon several central molecules, only some of which have been studied in the context of lung development. The central convergent molecules include retinoin, IGF1R, Akt and Tp53.
Retinoic acid, a metabolite of retinoin, promotes lung maturation and inhibits androgen receptor levels and function in several organs [24–27]. Further, testosterone has been shown to modulate retinoic acid activity in the lacrimal gland . miR-296-3p, miR-125a-5p, miR-342 and miR-486 have all been shown to be regulated by retinoic acid (Figure 2; Additional file 4). IGF signaling has also been shown to positively influence lung maturation and vascularization, processes that are negatively regulated by androgens . Futhermore, IGF1R may facitilate signaling of other growth factors known to affect fetal lung maturation in a sex-specific fashion, such as EGFR [12, 30]. miR-182 can regulate IGF1R expression (Figure 2; Additional file 4). IGFs have the ablity to regulate proliferation and differentiation, processes that play an important role in late lung development and account for sex differences. IGF1R total protein levels increase dramatically between gestational day 16.5 and 17.5, right at the onset of surfactant synthesis [31, 32]. Given our miRNA data, specific miRNAs can be linked with sex-specific changes in retinoic acid, androgen control and IGF signaling over an interval in lung development in which male infants are known to have a clinical disadvantage in disease related to delayed lung maturation.
Akt plays several important roles in development through control of cell proliferation, migration, apoptosis and transcription. Many of the differentially expressed miRNAs are involved in cellular responses to amino acid, growth factor, and hormonal stimuli based on GO Annotations of these miRNAs (Additional file 4). Several signaling molecules and receptors that are important in lung maturation, including EGFR, ErbB4, PDGF and insulin, activate Akt signaling. Of these, only EGFR is known to have a sex-specific development of expression and function in fetal lungs during this window of development [33, 34]. Pharmacological manipulations of Akt have also been shown to affect surfactant synthesis synthesis .
Other focal centers in the network include Tp53 and MAP2K4, both of which are tumor suppressor genes that are deregulated in lung cancer [36, 37]. In particular, miR-486, miR-24, miR-182, miR-615-3p and miR-125a-5p are regulated by Tp53 (Figure 2; Additional file 4). Little is known about the functions of Tp53 and MAP2K4 during lung development, though it is thought that p53 may be involved in alveolar epithelial cell differentiation .
Networks for miRNAs changing significantly with gestation
The cluster dendrogram for miRNAs that changed significanty with gestation is shown in Figure 3. The two central components of this network, based on previously established targets as identified by IPA analysis, are mediators of glucose metabolism (regulation of d-glucose production and of insulin production) and vascular endothelial growth factor A (VegfA) (Figure 4). Insulin binding to the insulin receptor (IR) regulates glucose uptake and metabolism, which is required to produce substrate for surfactant phospholipid synthesis . The IR, which is mainly expressed in the alveolar Type II cells, is developmentally regulated in its expression [39, 40]. Several of these differentially expressed miRNAs are associated with the insulin pathway. These include miR-24, miR-30e, miR-351, miR-26a and miR-27a (Figure 4; Additional file 4).
VEGFA helps coordinate lung epithelial and endothelial maturation. It is produced and secreted in late gestion lung by the alveolar epithelium and acts by binding to receptors on the vascular endothelium in the adjacent mesenchyme . As the lung progresses from the canalicular to saccular stage of development, VEGF levels increase as the alveolar sacs form and an air-blood interface becomes established. Further, several studies have shown that VEGFA mRNA expression increases towards the end of gestation [3, 42]. As shown by transgenic and knockout models, VEGFA levels are tightly regulated during lung development. Both increased and decreased expression of this factor is severely detrimental to vascular development, including lung vascular development, where it impacts saccular, alveolar and microvasculature development within the alveolar unit [43–45]. miR-126, in particular, enhances the proangiogenic effects of VEGF and FGF, by targeting SPRED1 . Several other miRNAs, such as miR-150, miR-504 and miR-322 have all been shown to regulate VEGFA expression (Figure 4).
Several other molecules with potential significance for lung development were also identified by the IPA analysis. These include fibronectin 1, Src, regulators of neurotransmitter function (NAPG, SLC38A1), regulators of protein synthesis and processing (GLANT7, SPRP), and those that control mitochondrial function (COX6Af2, ATPSG2). Of these, fibronectin has been most studied in lung development. Its expression is temporally regulated and helps to stabilize newly formed airways [47, 48].
The importance of miRNA control of gene expression through regulation of mRNA translation during fetal organ development is becoming increasingly recognized. MiRNAs regulate specific elements of cardiac morphogenesis, brain development, and hematologic development [49–51].
Previous profiles of miRNA expression in lungs have been published [3–7]. Overall, such studies have analyzed single time points across a wide span of the different stages of development and maturation. Our study adds to that information by providing a focused analysis of a specific window of development, specifically the progression from late pseudoglandular through the canalicular and further into the early saccular development stages. This is a crucial developmental period during which the lung becomes capable of the normal cellular and physiologic functions necessary for gas exchange to support life after birth. Dominant features of this crucial developmental interval are the development of Type II epithelial cell maturation for surfactant synthesis, the establishment of the microvascular network responsible for efficient gas exchange, and the thinning of the interstitial mesenchyme to promote an increase in epithelial surface area for efficient gas exchange. Using data from this array, we have gone on to study the role of specific miRNAs in lung airway and vascular development .
A major challenge for miRNA studies, whether profiling the microRNAome or studying an individual miRNA, is the identification of specific target proteins whose expression is mediated by specific miRNAs. Several valuable algorithms have been developed which predict miRNA targets based on the physical chemistry and codon sequences of mRNA molecules . Such algorithms commonly predict from tens to literally hundreds of potential targets for a given miRNA. Not surprisingly, the overwhelming majority of such predicted target molecules remain unvalidated. An additional difficulty is that such algorithms predict different targets, based on the parameters used to develop the algorithm. A pathway analysis tool such as IPA is a powerful tool for analyzing interactive networks involving multiple miRNA molecules based on previously established targets. By focusing the pathway analysis on those miRNAs which changed significantly during the interval studied, important clues can be obtained to direct subsequent focused studies of particular developmental events in order to identify specific targets.
Our analysis shows that of the large number of common miRNAs expressed in the mouse, only a relatively small number show significant developmental or sex-specific regulation during the interval studied. This suggests that miRNA targets are likely to be focused on processes central to the preparation for extrauterine life. Several of the core elements identified by the pathway analysis substantiate this conclusion. Molecules significant for vascular development, structural remodeling, cell metabolism, and cell proliferation and differentiation were prominent in the analytical trees. A particular value of the pathway analysis is that it facilitates identification of specific miRNAs that have been shown to be involved in these processes, making them a good starting point to be studied in the context of lung development. By focusing on miRNAs known to participate in specific processes (e.g. miR-126 in vascular formation), one can begin to tease out their roles in the developing lung.
The idea that miRNAs have sex dependent expression patterns is not new. In fact, miRNAs show sex-specificity during Embryonic Stem (ES) cell differentiation . Male and female differences in physiology and behavior are widely recognized as contributors to disparities in health outcomes. miRNAs are postulated to play an important role in the sexually dimorphic brain . Sex-based miRNA differences can also contribute to cardiac pathologies [56, 57]. Our data suggest that miRNAs may regulate sex differences in the lung. The role of androgens in regulating lung sex-specific differences during development has been well established . In light of this information it is likely that many of these miRNAs are androgen regulated and further studies would enable identification of androgen regulated miRNA pathways in the lung. However, it is possible that not all of the sex-specific miRNAs are regulated by androgens. Other factors, such as estrogen and TGFβ, have also been shown to contribute to sex-specific differences in lung .
A few of the miRNAs that were identified as significant in our analysis have been studied by other groups. Transgenic overexpression of the miR17-92 cluster altered proliferation and differentiation of lung progenitor cells, and Rbl2 was identified as a target of miR17-5p . A subsequent study showed that the miR-17 family can target Stat3 and Mapk14 to modulate FGF10-FGFR2b signaling, which is important in lung epithelial branching morphogenesis . The miR-302/367 cluster has been shown to regulate the balance between lung progenitor cell proliferation and differentiation, as well as progenitor cell polarity .
The results from this study should not be interpreted to indicate that overall only a few miRNAs are active in the control of lung development. It is highly probable that many molecules are under miRNA regulation which does not change within the interval studied. This is evident when our results are analyzed within the context of other studies which evaluated lungs at time points outside of the focus of our study. Our work does illustrate the value of a focused analysis to identify function-oriented targets of miRNA regulation, based on what is known about these specific miRNAs.
We have identified a set of miRNAs which exhibit either developmental or sex-specific expression differences during a crucial interval of lung development in preparation for birth. Pathway analysis identifies convergent interactive signaling networks that permit subsequent studies of focused identification and analysis of miRNA-target relationships, based on previously established targets. This has significant value in determining the role of miRNAs for development of the fetal lung.
MaryAnn V Volpe and Heber C Nielsen are co-senior authors.
RNA induced silencing complex
Insulin-like growth factor receptor 1
Insulin-like growth factor
Protein Kinase B
Tumor protein 53
Epidermal growth factor receptor
Platelet-derived growth factor
Vascular endothelial growth factor A
Du TT, Zamore PD: microPrimer: The biogenesis and function of microRNA. Development. 2005, 132 (21): 4645-4652. 10.1242/dev.02070.
Harris KS, Zhang Z, McManus MT, Harfe BD, Sun X: Dicer function is essential for lung epithelium morphogenesis. Proc Natl Acad Sci USA. 2006, 103 (7): 2208-2213. 10.1073/pnas.0510839103.
Dong J, Jiang G, Asmann YW, Tomaszek S, Jen J, Kislinger T, Wigle DA: MicroRNA networks in mouse lung organogenesis. PLoS One. 2010, 5 (5): e10854-10.1371/journal.pone.0010854.
Williams AE, Moschos SA, Perry MM, Barnes PJ, Lindsay MA: Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 2007, 236 (2): 572-580. 10.1002/dvdy.21047.
Yang Y, Kai G, Pu X, Qing K, Guo X, Zhou X: Expression profile of microRNAs in fetal lung development of Sprague–Dawley rats. Int J Mol Med. 2012, 29 (3): 393-402.
Lu Y, Okubo T, Rawlins E, Hogan BLM: Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc. 2008, 5 (3): 300-304. 10.1513/pats.200710-162DR.
Bhaskaran M, Wang Y, Zhang H, Weng T, Baviskar P, Guo Y, Gou D, Liu L: MicroRNA-127 modulates fetal lung development. Physiol Genomics. 2009, 37 (3): 268-278. 10.1152/physiolgenomics.90268.2008.
Maeda Y, Dave V, Whitsett JA: Transcriptional control of lung morphogenesis. Physiol Rev. 2007, 87 (1): 219-244. 10.1152/physrev.00028.2006.
Sayed D, Abdellatif M: MicroRNAs in development and disease. Physiol Rev. 2011, 91 (3): 827-887. 10.1152/physrev.00006.2010.
Fleisher B, Kulovich MV, Hallman M, Gluck L: Lung profile - Sex-differences in normal-pregnancy. Obstet Gynecol. 1985, 66 (3): 327-330.
Nielsen HC: Androgen receptors influence the production of pulmonary surfactant in the testicular feminization mouse fetus. J Clin Invest. 1985, 76 (1): 177-181. 10.1172/JCI111943.
Nielsen HC: Epidermal growth-factor influences the developmental clock regulating maturation of the fetal lung fibroblast. Biochim Biophys Acta. 1989, 1012 (2): 201-206. 10.1016/0167-4889(89)90097-9.
Nielsen HC, Torday JS: Sex differences in fetal lung development. Endochrinology of the lung. Edited by: Mendelson CR. 2000, 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512: Humana Press Inc, 141-159.
Bresson E, Seaborn T, Cote M, Cormier G, Provost PR, Piedboeuf B, Tremblay Y: Gene expression profile of androgen modulated genes in the murine fetal developing lung. Reprod Biol Endocrinol. 2010, 8: 2-10.1186/1477-7827-8-2.
Nielsen HC, Torday JS: Anatomy of fetal rabbit gonads and the sexing of fetal rabbits. Lab Anim. 1983, 17 (2): 148-150. 10.1258/002367783780959411.
R Development Core Team: R: A language and environment for statistical computing. 2010, Vienna, Austria: R foundation for statistical computing
Dabney A, Storey JD, Warnes GR: R package version 1.24.0. qvalue: Q-value estimation for false discovery rate control. 2010, [http://CRAN.R-project.org/package=qvalue]
Pinheiro J, Bates D, DebRoy S, Sarkar D, R Development Core Team: R package version 3.1-103. Nlme: linear and nonlinear mixed effects models. 2011, [http://www.R-project.org]
Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables B: R package version 2.8.0. gplots: Various R programming tools for plotting data (comprehensive R archive network). 2011, [http://cran.r-project.org/web/packages/gplots/index.html]
Seaborn T, Simard M, Provost PR, Piedboeuf B, Tremblay Y: Sex hormone metabolism in lung development and maturation. Trends Endocrinol Metab. 2010, 21 (12): 729-738. 10.1016/j.tem.2010.09.001.
Hanley K, Rassner U, Jiang Y, Vansomphone D, Crumrine D, Komuves L, Elias PM, Feingold KR, Williams ML: Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat - Acceleration by estrogen and delay by testosterone. J Clin Inves. 1996, 97 (11): 2576-2584. 10.1172/JCI118706.
Nielsen HC, Zinman HM, Torday JS: Dihydrotestosterone inhibits fetal rabbit pulmonary surfactant production. J Clin Invest. 1982, 69 (3): 611-616. 10.1172/JCI110488.
Torday JS, Nielsen HC: The Sex difference in fetal lung surfactant production. Exp Lung Res. 1987, 12 (1): 1-19. 10.3109/01902148709068811.
Schmidt AF, Goncalves FLL, Regis AC, Gallindo RM, Sbragia L: Prenatal retinoic acid improves lung vascularization and VEGF expression in CDH rat. Obstet Gynecol. 2012, 207 (1): 76.e25-10.1016/j.ajog.2012.04.025.
Ruttenstock E, Doi T, Dingemann J, Puri P: Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung. Birth Defects Res B Dev Reprod Toxicol. 2011, 92 (2): 148-151. 10.1002/bdrb.20293.
Liebeskind A, Srinivasan S, Kaetzel D, Bruce M: Retinoic acid stimulates immature lung fibroblast growth via a PDGF-mediated autocrine mechanism. Am J Physiol Lung Cell Mol Physiol. 2000, 279 (1): L81-L90.
Kumar S, Duester G: SnapShot: retinoic acid signaling. Cell. 2011, 147 (6): 1422-1422. 10.1016/j.cell.2011.11.034.
Ubels JL, Wertz JT, Ingersoll KE, Jackson RS, Aupperlee MD: Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid. Exp Eye Res. 2002, 75 (5): 561-571. 10.1006/exer.2002.2054.
Han R, Post M, Tanswell A, Lye S: Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am J Respir Cell Mol Biol. 2003, 28 (2): 159-169. 10.1165/rcmb.4764.
Coppola D, Ferber A, Miura M, Sell C, Dambrosio C, Rubin R, Baserga R: A functional insulin-like growth-factor-i receptor is required for the mitogenic and transforming activities of the epidermal growth-factor receptor. Mol Cell Biol. 1994, 14 (7): 4588-4595.
Nagata K, Masumoto K, Uesugi T, Yamamoto S, Yoshizaki K, Fukumoto S, Nonak K, Taguchi T: Effect of insulin-like-growth factor and its receptors regarding lung development in fetal mice. Pediatr Surg Int. 2007, 23 (10): 953-959. 10.1007/s00383-007-1977-8.
Oue T, Taira Y, Shima H, Miyazaki E, Puri P: Effect of antenatal glucocorticoid administration on insulin-like growth factor I and II levels in hypoplastic lung in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatr Surg Int. 1999, 15 (3–4): 175-179.
Klein JM, Nielsen HC: Androgen regulation of epidermal growth-factor receptor-binding activity during fetal rabbit lung development. J Clin Invest. 1993, 91 (2): 425-431. 10.1172/JCI116218.
Rosenblum D, Volpe M, Dammann C, Lo Y, Thompson J, Nielsen H: Expression and activity of epidermal growth factor receptor in late fetal rat lung is cell- and sex-specific. Exp Cell Res. 1998, 239 (1): 69-81. 10.1006/excr.1997.3888.
Wang J, Ito T, Udaka N, Okudela K, Yazawa T, Kitamura H: PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung. Tissue Cell. 2005, 37 (1): 25-35. 10.1016/j.tice.2004.09.002.
Ahn Y, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, Kurie JM: Map2k4 Functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor gamma 2 expression. Mol Cell Biol. 2011, 31 (21): 4270-4285. 10.1128/MCB.05562-11.
Brennan P, Hainaut P, Boffetta P: Genetics of lung-cancer susceptibility. Lancet Oncol. 2011, 12 (4): 399-408. 10.1016/S1470-2045(10)70126-1.
Tebar M, Boex J, Have-Opbroek A: Functional overexpression of wild-type p53 correlates with alveolar cell differentiation in the developing human lung. Anat Rec. 2001, 263 (1): 25-34. 10.1002/ar.1073.
Felts JM: Biochemistry of the lung. Health Phys. 1964, 10 (12): 973-979. 10.1097/00004032-196412000-00016.
Ulane RE, Graeber JE, Hansen JW, Liccini L, Cornblath M: Insulin-receptors in the developing fetal lung. Life Sc. 1982, 31 (26): 3017-3022. 10.1016/0024-3205(82)90069-8.
Kaner RJ, Crystal RG: Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med. 2001, 7 (4): 240-246.
Mariani TJ, Reed JJ, Shapiro SD: Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol. 2002, 26 (5): 541-548. 10.1165/ajrcmb.26.5.2001-00080c.
Tang KC, Rossiter HB, Wagner PD, Breen EC: Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol. 2004, 97 (4): 1559-1566. 10.1152/japplphysiol.00221.2004.
Zeng X, Wert SE, Federici R, Peters KG, Whitsett JA: VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn. 1998, 211 (3): 215-227. 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K.
Yamamoto H, Yun EJ, Gerber H, Ferrara N, Whitsett JA, Vu TH: Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol. 2007, 308 (1): 44-53. 10.1016/j.ydbio.2007.04.042.
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008, 15 (2): 261-271. 10.1016/j.devcel.2008.07.002.
Sakai T, Larsen M, Yamada KM: Fibronectin requirement in branching morphogenesis. Nature. 2003, 423 (6942): 876-881. 10.1038/nature01712.
Roman J: Fibronectin and fibronectin receptors in lung development. Exp Lung Res. 1997, 23 (2): 147-159. 10.3109/01902149709074027.
Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, Purton LE, Fleming HH, Cobb B, Merkenschlager M, Golub TR, Scadden DT: MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci USA. 2010, 107 (32): 14229-14234. 10.1073/pnas.0913574107.
Podolska A, Kaczkowski B, Busk PK, Sokilde R, Litman T, Fredholm M, Cirera S: MicroRNA expression profiling of the porcine developing brain. PLoS One. 2011, 6 (1): e14494-10.1371/journal.pone.0014494.
Cordes KR, Srivastava D: MicroRNA regulation of cardiovascular development. Circ Res. 2009, 104 (6): 724-732. 10.1161/CIRCRESAHA.108.192872.
Mujahid S, Nielsen HC, Volpe MV: MiR-221 and miR-130a regulate lung airway and vascular development. PLoS One. 2013, 8 (2): e55911-10.1371/journal.pone.0055911.
Bartel DP, Bartel D, Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136 (2): 215-233. 10.1016/j.cell.2009.01.002.
Ciaudo C, Servant N, Cognat V, Sarazin A, Kieffer E, Viville S, Colot V, Barillot E, Heard E, Voinnet O: Highly dynamic and sex-specific expression of microRNAs during early ES cell differentiation. PLoS Genet. 2009, 5 (8): e1000620-10.1371/journal.pgen.1000620.
Morgan CP, Bale TL: Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ. 2012, 3 (1): 22-10.1186/2042-6410-3-22.
Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF, Blelloch R: Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res. 2009, 105 (6): 585-594. 10.1161/CIRCRESAHA.109.200451.
Stauffer BL, Sobus RD, Sucharov CC: Sex differences in cardiomyocyte connexin43 expression. J Cardiovasc Pharmacol. 2011, 58 (1): 32-39. 10.1097/FJC.0b013e31821b70b4.
Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL: Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol. 2007, 310 (2): 442-453. 10.1016/j.ydbio.2007.08.007.
Carraro G, El-Hashash A, Guidolin D, Tiozzo C, Turcatel G, Young BM, De Langhe SP, Bellusci S, Shi W, Parnigotto PP, Warburton D: miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev Biol. 2009, 333 (2): 238-250. 10.1016/j.ydbio.2009.06.020.
Tian Y, Zhang Y, Hurd L, Hannenhalli S, Liu F, Lu MM, Morrisey EE: Regulation of lung endoderm progenitor cell behavior by miR302/367. Development. 2011, 138 (7): 1235-1245. 10.1242/dev.061762.
The authors are grateful for the assistance and suggestions from Lucia Pham. This work was supported by NIH HL037930, NIH HL085648, and the Peabody Foundation.
The authors declare that they have no competing interests of a financial or non-financial nature.
SM participated in the design of the study, carried out the experiments, performed the IPA analysis and participated in writing the manuscript. TL performed the array analysis and developed the heat map figures. MVV participated in the design of the study and in writing the manuscript. HCN participated in the design of the study and in writing the manuscript. All authors read and approved the final manuscript.